Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings
about
Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspectiveDiagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIFInfectious Diseases (ID) Learning Unit: How Rapidly to Evaluate for Active Tuberculosis Disease in Low-Prevalence Settings.Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis.Multidrug-resistant tuberculosis in transplant recipients: Case report and review of the literature.Detection of transrenal DNA for the diagnosis of pulmonary tuberculosis and treatment monitoring.Editorial Commentary: 1, 2, 3 (Years) … and You're Out: The End of a 123-year Historic Era.Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.Performance of a Highly Sensitive Mycobacterium tuberculosis Complex Real-Time PCR Assay for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting: a Prospective Intervention Study.A Comprehensive Evaluation of Xpert MTB/RIF Assay With Bronchoalveolar Lavage Fluid as a Single Test or Combined With Conventional Assays for Diagnosis of Pulmonary Tuberculosis in China: A Two-Center Prospective Study.The use of technology to improve health care to Saskatchewan's First Nations communities.Rapid molecular assays for detection of tuberculosis.New and Noteworthy in Tuberculosis Diagnostics and Treatment.
P2860
Q28074085-87069396-1A31-4F37-A666-6DB88DFA4762Q36353521-2F338F72-61DF-46E5-A72A-2FEDDC549046Q36900041-E765E967-094E-4B6C-8B50-603C54E1444CQ40104129-0DF279B9-D773-4F4A-8986-63C47C86C909Q40343382-7CE453FC-C6DE-4F6C-BF92-CCBC2EF0A5C0Q40474018-19E9CE1F-009E-41C4-AD3A-9FF2FE9F7CE4Q44598901-E76E63F6-5490-47C5-B3D7-8396FDB2C295Q47554066-80BE5FFA-18E3-49D0-AD34-3BF5634C7550Q52355547-FD1322CC-144C-4EE7-B560-EA55F5E51875Q52624528-966DC044-3ACC-4C43-8AFA-322F2B7E64C8Q55037031-4D039182-A87E-4088-B86A-26EB1D274D1CQ55366967-BC756E2B-54C8-4F13-B9C4-4B7DBBE915D3Q55503065-AC54FCEC-70B1-4F87-B9F7-0AA59F4999DC
P2860
Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Evaluation of Xpert MTB/RIF Ve ...... and Higher Prevalence Settings
@en
type
label
Evaluation of Xpert MTB/RIF Ve ...... and Higher Prevalence Settings
@en
prefLabel
Evaluation of Xpert MTB/RIF Ve ...... and Higher Prevalence Settings
@en
P2093
P2860
P50
P356
P1476
Evaluation of Xpert MTB/RIF Ve ...... and Higher Prevalence Settings
@en
P2093
AIDS Clinical Trials Group A5295 and Tuberculosis Trials Consortium Study 34 Teams
Beverly Metchock
David Alland
Debra A Benator
Edward Telzak
Elizabeth Guy
Fred Sattler
Gerald H Mazurek
Ian M Sanne
Marc Weiner
P2860
P304
P356
10.1093/CID/CIW035
P407
P577
2016-02-02T00:00:00Z